BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3008070)

  • 21. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
    Kasch R; Meissner J; Haack D; Neumann S
    Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and progesterone receptors revealed by an immunoperoxidase method.
    Pelusi G; D'Errico A; Cavallina R; Cunsolo A; Jasonni VM; Eusebi V
    Eur J Gynaecol Oncol; 1983; 4(2):94-6. PubMed ID: 6191985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
    McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
    Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fluorescence microscopy determination of estrogen receptor activity in breast cancer].
    Frank K; Heine M; Remmele W
    Pathologe; 1980 Nov; 2(1):51-5. PubMed ID: 6258170
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognostic value of hormonal receptors determined by a histochemical method in operable carcinoma of the breast. Multicenter study].
    Baiocchi C; De Crescenzo S; Ferrari M
    Pathologica; 1987; 79(1059-1060):149-57. PubMed ID: 3327040
    [No Abstract]   [Full Text] [Related]  

  • 26. Estrogen receptors in breast cancer; relationship to age, menstrual status and histological type.
    Gómez P; Luna G; Beltrán ME; Hernández F
    Arch Invest Med (Mex); 1987; 18(1):31-6. PubMed ID: 2820332
    [No Abstract]   [Full Text] [Related]  

  • 27. [Estrogen and progresterone receptors in male breast diseases].
    Contesso G; Delarue JC; Guerinot F; May-Levin F; Bohuon C
    Nouv Presse Med; 1977 May; 6(22):1951-3. PubMed ID: 887385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of histologically determined receptor state and the clinical course in tumors of the breast].
    Ghislandi E; Gottardi O
    Pathologica; 1985; 77(1049):323-35. PubMed ID: 3831883
    [No Abstract]   [Full Text] [Related]  

  • 29. [Receptor correlation between histochemical and biochemical methods in advanced breast carcinoma].
    Simone G; Paradiso A; Labriola A; Petroni S; Tommasi S; Schittulli F
    Pathologica; 1987; 79(1059-1060):113-8. PubMed ID: 3441401
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morphometric correlates of the steroid receptor content in invasive ductal breast cancers].
    Mattfeldt T; Neurohr W; Müller A; Klinga K
    Verh Dtsch Ges Pathol; 1985; 69():350-5. PubMed ID: 3006385
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison between a biochemical and a histochemical method for the detection of oestrogen receptor in breast carcinoma.
    McMahon RT; Connolly CE
    Ir J Med Sci; 1985 May; 154(5):187-92. PubMed ID: 2993194
    [No Abstract]   [Full Text] [Related]  

  • 32. [Correlation between receptor status histochemically determined and clinical course in tumors of the breast: execution and extension of the study].
    Gottardi O; Franchi L; Ghislandi E
    Pathologica; 1987; 79(1059-1060):141-7. PubMed ID: 3441404
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy].
    Saito K; Hotta T; Kobayashi S; Miura I; Sakuma S; Shimozato T; Torii T; Iwase H; Satake A; Nishida T
    Gan No Rinsho; 1985 Oct; 31(13):1727-30. PubMed ID: 3001383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 35. Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies.
    Pertschuk LP; Tobin EH; Gaetjens E; Carter AC; Degenshein GA; Bloom ND; Brigati DJ
    Cancer; 1980 Dec; 46(12 Suppl):2896-901. PubMed ID: 6256056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Receptor status of cytologic material in primary and secondary breast tumors].
    Stagni F; Lampertico P
    Pathologica; 1987; 79(1059-1060):125-30. PubMed ID: 3441402
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rosser RJ
    Cancer; 2003 Sep; 98(5):1102-3; author reply 1103. PubMed ID: 12942582
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prognostic value of receptor state determined by radiometric method in breast carcinoma].
    Campobasso O; Chasseur D; Concina S; Conti G; Cozzani C; Racca S
    Pathologica; 1985; 77(1049):315-21. PubMed ID: 3831882
    [No Abstract]   [Full Text] [Related]  

  • 39. [Radiometric determination of E2 and Pg and quality control].
    Piffanelli A
    Pathologica; 1987; 79(1059-1060):27-32. PubMed ID: 3441408
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estrogen receptors and clinical prognostic factors in breast cancer].
    Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
    Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.